Palatin Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTN and other ETFs, options, and stocks.

About PTN

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). 

CEO
Carl Spana
CEOCarl Spana
Employees
34
Employees34
Headquarters
Cranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded
1986
Founded1986
Employees
34
Employees34

PTN Key Statistics

Market cap
26.14M
Market cap26.14M
Price-Earnings ratio
-0.62
Price-Earnings ratio-0.62
Dividend yield
Dividend yield
Average volume
341.42K
Average volume341.42K
High today
$1.73
High today$1.73
Low today
$1.52
Low today$1.52
Open price
$1.56
Open price$1.56
Volume
369.41K
Volume369.41K
52 Week high
$5.65
52 Week high$5.65
52 Week low
$1.43
52 Week low$1.43
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.